BridGene Biosciences Appoints Nobel Laureate Bruce A. Beutler, M.D., to Scientific Advisory Board
PR Newswire —
Pioneering immunologist and genetics leader to advise on advancement of novel small-molecule therapeutics for hard-to-drug targets SAN JOSE, Calif., Jan. 5, 2026 /PRNewswire/ -- BridGene Biosciences, Inc., a leader in the discovery of small-molecule drugs for traditionally "hard-to-drug"...